Search research articles
Contact Us
Filters
Showing results (41-50 of 468) with videos related to
Page
of 47
Sort By:
Journal of the National Cancer Institute
|
October 24, 2017
Real-world Data for Clinical Evidence Generation in Oncology
Sean Khozin, Gideon M Blumenthal, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2024
The Retrofit: Lessons From Sotorasib's Dosing Conundrum
Harpreet Singh, Paz J Vellanki, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
End points and United States Food and Drug Administration approval of oncology drugs
John R Johnson, Grant Williams, Richard Pazdur
The New England Journal of Medicine
|
April 20, 2017
Reevaluating Eligibility Criteria - Balancing Patient Protection and Participation in Oncology Trials
Julia A Beaver, Gwynn Ison, Richard Pazdur
JCO Oncology Practice
|
June 29, 2023
Advancing Therapies for Asian Americans, Native Hawaiians, and Other Pacific Islanders With Cancer: OCE's Project ASIATICA
Jennifer J Gao, Richard Pazdur, Tamy Kim
JAMA Oncology
|
October 8, 2020
US Food and Drug Administration Support for Oncology Drug Development During COVID-19
Kushal T Kadakia, Richard Pazdur, Anand Shah
The Oncologist
|
September 10, 2009
Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer
Martin H Cohen, Robert Justice, Richard Pazdur
JAMA Oncology
|
November 6, 2015
Next-Generation Sequencing in Oncology in the Era of Precision Medicine
Gideon M Blumenthal, Elizabeth Mansfield, Richard Pazdur
JAMA Oncology
|
September 16, 2016
Minimal Residual Disease as a Potential Surrogate End Point-Lingering Questions
Nicole J Gormley, Ann T Farrell, Richard Pazdur
JAMA Oncology
|
June 30, 2017
Treatment Beyond Progression With Immune Checkpoint Inhibitors-Known Unknowns
Gideon M Blumenthal, Marc R Theoret, Richard Pazdur
Page
of 47
Search research articles
Search
Showing results (41-50 of 468) with videos related to
Sort By:
Page
of 47
Journal of the National Cancer Institute
|
October 24, 2017
Real-world Data for Clinical Evidence Generation in Oncology
Sean Khozin, Gideon M Blumenthal, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2024
The Retrofit: Lessons From Sotorasib's Dosing Conundrum
Harpreet Singh, Paz J Vellanki, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
End points and United States Food and Drug Administration approval of oncology drugs
John R Johnson, Grant Williams, Richard Pazdur
The New England Journal of Medicine
|
April 20, 2017
Reevaluating Eligibility Criteria - Balancing Patient Protection and Participation in Oncology Trials
Julia A Beaver, Gwynn Ison, Richard Pazdur
JCO Oncology Practice
|
June 29, 2023
Advancing Therapies for Asian Americans, Native Hawaiians, and Other Pacific Islanders With Cancer: OCE's Project ASIATICA
Jennifer J Gao, Richard Pazdur, Tamy Kim
JAMA Oncology
|
October 8, 2020
US Food and Drug Administration Support for Oncology Drug Development During COVID-19
Kushal T Kadakia, Richard Pazdur, Anand Shah
The Oncologist
|
September 10, 2009
Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer
Martin H Cohen, Robert Justice, Richard Pazdur
JAMA Oncology
|
November 6, 2015
Next-Generation Sequencing in Oncology in the Era of Precision Medicine
Gideon M Blumenthal, Elizabeth Mansfield, Richard Pazdur
JAMA Oncology
|
September 16, 2016
Minimal Residual Disease as a Potential Surrogate End Point-Lingering Questions
Nicole J Gormley, Ann T Farrell, Richard Pazdur
JAMA Oncology
|
June 30, 2017
Treatment Beyond Progression With Immune Checkpoint Inhibitors-Known Unknowns
Gideon M Blumenthal, Marc R Theoret, Richard Pazdur
Page
of 47